Anne Kresinsky
Jena, TH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
CRISPR/Cas9-Mediated Modification of PTP Expression.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 26, 2023
Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITD.
Journal: Frontiers in oncology
Published: August 12, 2022
Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia Cells.
Journal: Antioxidants (Basel, Switzerland)
Published: January 02, 2022
Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.
Journal: Leukemia
Published: January 18, 2020
The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.
Journal: Leukemia
Published: June 21, 2019
SHP1 regulates a STAT6-ITGB3 axis in FLT3ITD-positive AML cells.
Journal: Leukemia
Published: January 23, 2019
Loss of DEP-1 (Ptprj) promotes myeloproliferative disease in FLT3-ITD acute myeloid leukemia.
Journal: Haematologica
Published: June 09, 2018
PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.
Journal: Oncotarget
Published: November 30, 2017
Phagocytosis of bone marrow derived macrophages is controlled by phosphoinositide 3-kinase γ.
Journal: Immunology letters
Published: May 19, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026